News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Conference News AHA 2018 VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer Shelley Wood November 10, 2018
News Daily News Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows Michael O'Riordan November 06, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Daily News CAC Scoring Is Predictive of Risk Across Races and Ethnicities L.A. McKeown October 16, 2018
News Daily News Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks Michael O'Riordan October 15, 2018
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018
News Daily News Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’ Todd Neale September 13, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Daily News ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes Todd Neale August 17, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Daily News New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients Michael O'Riordan August 13, 2018
News Daily News Peer Pressure May Push Physicians to Do Better at Prescribing Statins Lucy Hicks July 30, 2018
News Daily News Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention? Todd Neale July 20, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Daily News All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout Caitlin E. Cox June 19, 2018
News Daily News NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin L.A. McKeown May 16, 2018